Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

uniQure N.V. (QURE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.76+0.84 (+4.69%)
At close: 04:00PM EDT
18.90 +0.14 (+0.75%)
After hours: 06:38PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close17.92
Open17.85
Bid18.10 x 1200
Ask19.42 x 2200
Day's Range17.85 - 19.30
52 Week Range12.52 - 36.55
Volume464,831
Avg. Volume684,300
Market Cap866.978M
Beta (5Y Monthly)0.88
PE Ratio (TTM)N/A
EPS (TTM)-2.81
Earnings DateOct 24, 2022 - Oct 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est52.19
  • GlobeNewswire

    uniQure to Participate in Upcoming Industry Conferences in September

    LEXINGTON, Mass. and AMSTERDAM, Sept. 06, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming investor and scientific conferences: Citi’s 17th Annual BioPharma Conference, September 7 – 8, 2022 Members of uniQure’s management team, including Matt Kapusta, chief executive officer, and Ricardo Dolmetsch, Ph.D., president of research

  • Simply Wall St.

    These Analysts Just Made A Neat Downgrade To Their uniQure N.V. (NASDAQ:QURE) EPS Forecasts

    The latest analyst coverage could presage a bad day for uniQure N.V. ( NASDAQ:QURE ), with the analysts making...

  • Motley Fool

    Why uniQure Stock Is Crashing Today

    Shares of uniQure N.V. (NASDAQ: QURE) are crashing today, down by 32.6% as of 11:19 a.m. ET. The steep decline came after the gene therapy specialist provided its second-quarter update Monday morning. Investors weren't all that interested in uniQure's financial results.

Advertisement
Advertisement